Vivosim Labs, Inc. (VIVS) — 10-Q Filings
All 10-Q filings from Vivosim Labs, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
VivoSim Shifts Focus Amidst Continued Losses, Cash Drains
— Nov 6, 2025 Risk: high
VivoSim Labs, Inc. (VIVS) reported a net loss of $2.545 million for the three months ended September 30, 2025, a slight improvement from the $2.549 million net -
VivoSim Labs' Q1 Loss Widens Amidst Revenue Dip, R&D Spend Rises
— Aug 12, 2025 Risk: high
VivoSim Labs, INC. (VIVS) reported a net loss of $2.2 million for the quarter ended June 30, 2025, a significant increase from the $1.8 million net loss in the -
Organovo Holdings Files Q3 FY25 10-Q
— Feb 19, 2025 Risk: medium
Organovo Holdings, Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the third quarter of their fiscal year 2025. Key financial det -
Organovo Holdings 10-Q: Q2 FY25 Financials Released
— Nov 8, 2024 Risk: medium
Organovo Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the second -
Organovo Holdings Files 10-Q for Q2 2024
— Aug 5, 2024 Risk: medium
Organovo Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates. Key financial data -
Organovo Holdings, Inc. Files 10-Q for Period Ending December 31, 2023
— Feb 8, 2024 Risk: low
ORGANOVO HOLDINGS, INC. (VIVS) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. Organovo Holdings, Inc. filed a 10-Q report for the period endi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX